Buffington Mohr McNeal’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.52M | Sell |
61,540
-17,031
| -22% | -$1.59M | 1.09% | 31 |
|
|
2024
Q4 | $7.82M | Sell |
78,571
-5,155
| -6% | -$531K | 1.3% | 29 |
|
|
2024
Q3 | $9.51M | Buy |
83,726
+588
| +0.7% | +$69.9K | 1.56% | 23 |
|
|
2024
Q2 | $10.3M | Buy |
83,138
+351
| +0.4% | +$45.2K | 1.81% | 23 |
|
|
2024
Q1 | $10.9M | Buy |
82,787
+6,041
| +8% | +$745K | 1.98% | 20 |
|
|
2023
Q4 | $8.37M | Buy |
76,746
+328
| +0.4% | +$34K | 1.68% | 25 |
|
|
2023
Q3 | $7.87M | Sell |
76,418
-1,405
| -2% | -$151K | 1.79% | 21 |
|
|
2023
Q2 | $8.98M | Sell |
77,823
-3,393
| -4% | -$385K | 1.94% | 21 |
|
|
2023
Q1 | $8.64M | Buy |
81,216
+1,089
| +1% | +$118K | 1.98% | 17 |
|
|
2022
Q4 | $8.89M | Sell |
80,127
-1,925
| -2% | -$197K | 2.07% | 17 |
|
|
2022
Q3 | $7.07M | Buy |
82,052
+1,720
| +2% | +$154K | 1.7% | 18 |
|
|
2022
Q2 | $7.32M | Buy |
80,332
+294
| +0.4% | +$26.1K | 1.61% | 20 |
|
|
2022
Q1 | $6.57M | Buy |
80,038
+2,485
| +3% | +$196K | 1.24% | 29 |
|
|
2021
Q4 | $5.94M | Buy |
77,553
+1,242
| +2% | +$98.9K | 1.02% | 34 |
|
|
2021
Q3 | $5.73M | Buy |
76,311
+2,577
| +3% | +$196K | 1.1% | 33 |
|
|
2021
Q2 | $5.73M | Buy |
73,734
+707
| +1% | +$52.6K | 1.12% | 30 |
|
|
2021
Q1 | $5.37M | Buy |
73,027
+58,643
| +408% | +$4.33M | 1.15% | 27 |
|
|
2020
Q4 | $1.12M | Buy |
14,384
+2,216
| +18% | +$169K | 0.26% | 59 |
|
|
2020
Q3 | $963K | Buy |
12,168
+1,361
| +13% | +$107K | 0.25% | 64 |
|
|
2020
Q2 | $797K | Buy |
10,807
+1,501
| +16% | +$113K | 0.22% | 71 |
|
|
2020
Q1 | $683K | Buy |
9,306
+2,274
| +32% | +$179K | 0.23% | 67 |
|
|
2019
Q4 | $610K | Hold |
7,032
| – | – | 0.17% | 86 |
|
|
2019
Q3 | $565K | Sell |
7,032
-367
| -5% | -$29.4K | 0.17% | 84 |
|
|
2019
Q2 | $592K | Sell |
7,399
-279
| -4% | -$21.4K | 0.19% | 85 |
|
|
2019
Q1 | $609K | Sell |
7,678
-31
| -0.4% | -$2.32K | 0.2% | 84 |
|
|
2018
Q4 | $562K | Buy |
7,709
+244
| +3% | +$17.2K | 0.23% | 83 |
|
|
2018
Q3 | $505K | Hold |
7,465
| – | – | 0.17% | 93 |
|
|
2018
Q2 | $432K | Buy |
+7,465
| New | +$421K | 0.16% | 95 |
|
|
2017
Q3 | – | Sell |
-4,368
| Closed | -$267K | – | 132 |
|
|
2017
Q2 | $267K | Buy |
+4,368
| New | +$266K | 0.11% | 124 |
|
|
2016
Q2 | – | Sell |
-4,402
| Closed | -$222K | – | 168 |
|
|
2016
Q1 | $222K | Buy |
+4,402
| New | +$216K | 0.1% | 121 |
|
Other funds holding MRK
Buffington Mohr McNeal's MRK Position: Q1 2025 in Review
Buffington Mohr McNeal reduced its Merck (MRK) stake by 22% in Q1 2025, selling an estimated $1.59M and leaving 61,540 shares worth $5.52M. The position accounts for 1.09% of the portfolio, ranked #31.
Buffington Mohr McNeal first reported a position in MRK in Q1 2016 and has held it in 30 quarters since. The position peaked at $10.9M in Q1 2024. 3,448 funds tracked by Wall St. Rank hold MRK as of Q1 2025.
- Buffington Mohr McNeal held 61,540 shares of Merck worth $5.52M as of Q1 2025.
- Buffington Mohr McNeal sold 17,031 Merck shares in Q1 2025, an estimated $1.59M.
- Merck made up 1.09% of Buffington Mohr McNeal's portfolio in Q1 2025, its #31 holding.
- Buffington Mohr McNeal first reported a position in Merck in Q1 2016 and has held it in 30 quarters since.
- Buffington Mohr McNeal's Merck position peaked at $10.9M in Q1 2024.
- 3,448 funds tracked by Wall St. Rank held Merck as of Q1 2025.
Based on Buffington Mohr McNeal's 13F filing for Q1 2025, filed 28 Apr 2025.